FDA drafts pharma exec prosecution guidelines

The FDA has drafted guidelines for selecting the cases in which it will pursue misdemeanor prosecutions of corporate officers, holding them accountable for lingering GMP breaches and other violations of the Food, Drug and Cosmetics Act. The guidelines are being reviewed internally, reports law firm Bryan Cave, and the regulator expects to make public the final version. Item 

Sponsored By Digital Pharma Europe

Fierce Pharma Marketing is excited to announce the first virtual Digital Pharma Europe!

This summit will profile best-in-class case studies and senior-level discussions from leaders who are innovating the way we look at the intersection of digital technologies and marketing in Europe.